Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
Lieven Janssens, Kaneka Eurogentec’s President and CEO, said, “Manufacturing GMP mRNA complements perfectly our ongoing GMP DNA manufacturing activities...
It’s definitely the ambition of Kaneka Eurogentec to become the world leading CDMO for mRNA, as we are already for the production of plasmid DNA.”...
Two mRNA contracts already signed The expertise of the company for more than 25 years as CDMO for the manufacturing of GMP Biopharmaceuticals is recognized
It’s definitely the ambition of Kaneka Eurogentec to become the world leading CDMO for mRNA, as we are already for the production of plasmid DNA.”...
Two mRNA contracts already signed The expertise of the company for more than 25 years as CDMO for the manufacturing of GMP Biopharmaceuticals is recognized